Jones Financial Companies’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.57K Sell
76
-94
-55% -$1.77K ﹤0.01% 4498
2026
Q1
$2.88K Buy
170
+120
+240% +$2.38K ﹤0.01% 4044
2025
Q4
$982 Hold
50
﹤0.01% 4020
2025
Q3
$1.43K Hold
50
﹤0.01% 3800
2025
Q2
$1.56K Buy
+50
New +$1.42K ﹤0.01% 3542
2025
Q1
Sell
-9
Closed -$323 3869
2024
Q4
$323 Buy
+9
New +$337 ﹤0.01% 3274

Other funds holding USNA

Jones Financial Companies's USNA Position: Q2 2026 in Review

Jones Financial Companies reduced its Usana Health Sciences (USNA) stake by 55% in Q2 2026, selling an estimated $1.77K and leaving 76 shares worth $1.57K. The position accounts for ﹤0.01% of the portfolio, ranked #4498.

Jones Financial Companies first reported a position in USNA in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.88K in Q1 2026. 138 funds tracked by Wall St. Rank hold USNA as of Q2 2026.

  • Jones Financial Companies held 76 shares of Usana Health Sciences worth $1.57K as of Q2 2026.
  • Jones Financial Companies sold 94 Usana Health Sciences shares in Q2 2026, an estimated $1.77K.
  • Usana Health Sciences made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4498 holding.
  • Jones Financial Companies first reported a position in Usana Health Sciences in Q4 2024 and has held it in 6 quarters since.
  • Jones Financial Companies's Usana Health Sciences position peaked at $2.88K in Q1 2026.
  • 138 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.